R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2024
Voltar para busca
Dado oficial do USPTO
AXIAL THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
10/04/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42, 44
Data de depósito
28/09/2020
Data de registro
09/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/04/2024
Última transação
10/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/10/2022
Primeiro uso no comércio
01/10/2022
Código do desenho
3
Tipo de titular
03
Localização do titular
WOBURN, MA
Examinador
MASON,JARED MICHAEL
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of eight circles, each connected to a central donut circle by two horizontal lines at the left and right, one shorter vertical line at the top, one longer vertical line at the bottom, one short diagonal line at the lower-left, one longer diagonal line at the upper-left, one slightly longer diagonal line at the upper-right, and one longer diagonal line at the lower right. To the right of this is the stacked stylized wording "AXIAL THERAPEUTICS" where "AXIAL" is in larger-sized font and "THERAPEUTICS" is in smaller-sized font.
Titulares e representantes
Titulares
AXIAL THERAPEUTICS, INC.
Axial Biotherapeutics, Inc.
Representantes
Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalsbiochemicalscellsmicrobes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparationsfor in vitro and in vivo scientific or research usefor use in industry and science; chemicalbiochemical and microbial productsone or more of small moleculesproteinsantibodiesnucleic acidsprobiotic bacteriaprobiotic bacterial culturesmicrobes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatmentpreventiondetection of central nervous system diseases and disorderscancertumorsfibrosisinflammationmicrobe-related and microbiome-related conditionsgastrointestinal and immunological diseasesany disease or disorder associated with intestinal permeabilityleaky gutamyloids
Classe 5
Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatmentpreventiondetection of central nervous system diseases and disorderscancertumorsfibrosisinflammationmicrobe-related and microbiome-related conditionsgastrointestinal and immunological diseasesany disease or disorder associated with intestinal permeabilityleaky gutamyloids; chemicalbiochemical and microbial productsone or more of small moleculesproteinsantibodiesnucleic acidsprobiotic bacteriaprobiotic bacterial culturesmicrobes being pharmaceutical preparations and substances for the treatmentpreventiondetection of central nervous system diseases and disorderscancertumorsfibrosisinflammationmicrobe-related and microbiome-related conditionsgastrointestinal and immunological diseasesany disease or disorder associated with intestinal permeabilityleaky gutamyloids
Classe 42
Providing medical and scientific research information in the fields of pharmaceuticalsbiochemistrybiotechnologyclinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistrybiotechnologyconducting clinical trials for others
Classe 44
Providing medical information in the fields of diagnosticprophylactictherapeutic properties of probiotic or microbe-targeted pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/03/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/02/2024
ALIE
ASSIGNED TO LIE
26/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2023
EEXT
SOU TEAS EXTENSION RECEIVED
18/07/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
21/06/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
21/06/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2023
GNRT
NON-FINAL ACTION E-MAILED
04/04/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/04/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/03/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/03/2023
IUAF
USE AMENDMENT FILED
17/02/2023
EISU
TEAS STATEMENT OF USE RECEIVED
17/02/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/01/2023
EX2G
SOU EXTENSION 2 GRANTED
11/01/2023
EXT2
SOU EXTENSION 2 FILED
11/01/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/06/2022
EX1G
SOU EXTENSION 1 GRANTED
17/06/2022
EXT1
SOU EXTENSION 1 FILED
17/06/2022
EEXT
SOU TEAS EXTENSION RECEIVED
17/06/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/11/2021
PUBO
PUBLISHED FOR OPPOSITION
23/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/09/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
24/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/03/2021
GNRT
NON-FINAL ACTION E-MAILED
22/03/2021
CNRT
NON-FINAL ACTION WRITTEN
22/03/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
25/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
25/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/02/2021
DOCK
ASSIGNED TO EXAMINER
19/02/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/11/2020
NWAP
NEW APPLICATION ENTERED
01/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AXIAL THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.